NO912848L - Substituerte azoler, fremgangsmaate for fremstilling deravog anvendelse av forbindelsene. - Google Patents
Substituerte azoler, fremgangsmaate for fremstilling deravog anvendelse av forbindelsene.Info
- Publication number
- NO912848L NO912848L NO91912848A NO912848A NO912848L NO 912848 L NO912848 L NO 912848L NO 91912848 A NO91912848 A NO 91912848A NO 912848 A NO912848 A NO 912848A NO 912848 L NO912848 L NO 912848L
- Authority
- NO
- Norway
- Prior art keywords
- azols
- substituted
- compounds
- procedure
- manufacturing
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4023215A DE4023215A1 (de) | 1990-07-21 | 1990-07-21 | Substituierte azole, verfahren zu deren herstellung, sie enthaltende mittel und deren verwendung |
Publications (4)
Publication Number | Publication Date |
---|---|
NO912848D0 NO912848D0 (no) | 1991-07-19 |
NO912848L true NO912848L (no) | 1992-01-22 |
NO179283B NO179283B (no) | 1996-06-03 |
NO179283C NO179283C (no) | 1996-09-11 |
Family
ID=6410744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO912848A NO179283C (no) | 1990-07-21 | 1991-07-19 | Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler |
Country Status (19)
Country | Link |
---|---|
US (1) | US5225414A (no) |
EP (1) | EP0468372A3 (no) |
JP (1) | JPH04234388A (no) |
KR (1) | KR920002598A (no) |
CN (1) | CN1031404C (no) |
AU (1) | AU648323B2 (no) |
CA (1) | CA2047467A1 (no) |
CZ (1) | CZ280584B6 (no) |
DE (1) | DE4023215A1 (no) |
FI (1) | FI95254C (no) |
HU (2) | HU212420B (no) |
IE (1) | IE912550A1 (no) |
IL (1) | IL98898A (no) |
NO (1) | NO179283C (no) |
NZ (1) | NZ239039A (no) |
PT (1) | PT98369B (no) |
RU (1) | RU2047604C1 (no) |
YU (1) | YU126291A (no) |
ZA (1) | ZA915683B (no) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4010797A1 (de) * | 1990-04-04 | 1991-10-10 | Hoechst Ag | Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung |
DE4036706A1 (de) * | 1990-11-17 | 1992-05-21 | Hoechst Ag | Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie |
US5616599A (en) * | 1991-02-21 | 1997-04-01 | Sankyo Company, Limited | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
US5177074A (en) * | 1991-03-26 | 1993-01-05 | Merck & Co., Inc. | Angiotensin ii antagonists incorporating a substituted thiophene or furan |
US5252574A (en) * | 1991-04-26 | 1993-10-12 | Merck & Co., Inc. | Angiotensin II antagonists incorporating a substituted thiophene or furan |
US5198438A (en) * | 1991-05-07 | 1993-03-30 | Merck & Co., Inc. | Angiotensin ii antagonists incorporating a substituted thiophene or furan |
US5364869A (en) * | 1992-03-09 | 1994-11-15 | Abbott Laboratories | Heterocycle-substituted benzyaminopyridine angiotensin II receptor antagonists |
TW259786B (no) * | 1992-12-17 | 1995-10-11 | Sankyo Co | |
US5338740A (en) * | 1993-07-13 | 1994-08-16 | Pfizer Inc. | Angiotensin II receptor antagonists |
US5677302A (en) * | 1996-02-26 | 1997-10-14 | Apotex Inc. | Thiadiazole compounds useful as proton pump inhibitors |
DE19645313A1 (de) | 1996-11-04 | 1998-05-07 | Basf Ag | Substituierte 3-Benzylpyrazole |
SE9903028D0 (sv) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
US7125903B1 (en) | 1999-09-14 | 2006-10-24 | Aventis Pharmaceuticals Inc. | Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists |
US7091199B1 (en) | 1999-09-14 | 2006-08-15 | Aventis Pharmaceuticals Inc. | Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists |
US7253165B2 (en) * | 1999-09-14 | 2007-08-07 | Aventis Pharmaceuticals Inc. | Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists |
GB0016787D0 (en) | 2000-07-07 | 2000-08-30 | Pfizer Ltd | Compounds useful in therapy |
CN1678608A (zh) * | 2002-07-02 | 2005-10-05 | 先灵公司 | 新的神经肽yy5受体拮抗剂 |
US20070054948A1 (en) * | 2004-09-02 | 2007-03-08 | Lilach Hedvati | Purification of olmesartan medoxomil |
CA2575177A1 (en) * | 2004-09-02 | 2006-03-16 | Teva Pharmaceutical Industries Ltd. | Purification of olmesartan medoxomil |
IN2014DN02217A (no) | 2005-04-12 | 2015-07-10 | Vicore Pharma Ab | |
JP5202301B2 (ja) | 2005-04-12 | 2013-06-05 | ヴィコール・ファルマ・アーベー | 新規な三環系アンジオテンシンiiアゴニスト |
AU2006235706B2 (en) | 2005-04-12 | 2012-03-08 | Vicore Pharma Ab | New tricyclic angiotensin II agonists |
US7879802B2 (en) | 2007-06-04 | 2011-02-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
US8188083B2 (en) | 2007-06-28 | 2012-05-29 | Abbott Laboratories | Triazolopyridazines |
EP3239170B1 (en) | 2008-06-04 | 2019-03-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
EP3241839B1 (en) | 2008-07-16 | 2019-09-04 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
CN106866667B (zh) | 2009-11-05 | 2019-11-15 | 圣母大学 | 咪唑并[1,2-a]吡啶类化合物及其合成及使用方法 |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
US8703776B2 (en) | 2011-06-15 | 2014-04-22 | Cymabay Therapeutics, Inc. | Agonists of GPR131 and uses thereof |
WO2013032939A1 (en) * | 2011-08-26 | 2013-03-07 | Metabolex, Inc. | Bicyclic agonists of gpr131 and uses thereof |
CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
JP6606491B2 (ja) | 2013-06-05 | 2019-11-13 | シナジー ファーマシューティカルズ インコーポレイテッド | グアニル酸シクラーゼcの超高純度アゴニスト、その作成および使用方法 |
CA2998375A1 (en) | 2015-09-17 | 2017-03-23 | Marvin J. Miller | Benzyl amine-containing heterocyclic compounds and compositions useful against mycobacterial infection |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH489510A (de) * | 1967-02-07 | 1970-04-30 | Geigy Ag J R | Verfahren zur Herstellung von substituierten v-Triazolen |
DK151884C (da) * | 1979-03-07 | 1988-06-13 | Pfizer | Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf |
DE3310197A1 (de) * | 1983-03-21 | 1984-09-27 | A. Nattermann & Cie GmbH, 5000 Köln | Substituierte 3-mercapto-pyridazine und deren 3-alkylthioderivate sowie verfahren zu ihrer herstellung |
CA1334092C (en) * | 1986-07-11 | 1995-01-24 | David John Carini | Angiotensin ii receptor blocking imidazoles |
DE3702758A1 (de) * | 1987-01-30 | 1988-09-29 | Hoechst Ag | Substituierte 3-phenyl-7h-thiazolo (3,2-b) (1,2,4) triazin-7-one, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung, sowie einige bei der herstellung der genannten verbindungen gebildete zwischenprodukte |
US5015651A (en) * | 1988-01-07 | 1991-05-14 | E. I. Du Pont De Nemours And Company | Treatment of hypertension with 1,2,4-angiotensin II antagonists |
IE64514B1 (en) * | 1989-05-23 | 1995-08-09 | Zeneca Ltd | Azaindenes |
IE70593B1 (en) * | 1989-09-29 | 1996-12-11 | Eisai Co Ltd | Biphenylmethane derivative the use of it and pharmacological compositions containing same |
DE4010797A1 (de) * | 1990-04-04 | 1991-10-10 | Hoechst Ag | Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung |
-
1990
- 1990-07-21 DE DE4023215A patent/DE4023215A1/de not_active Withdrawn
-
1991
- 1991-07-17 YU YU126291A patent/YU126291A/sh unknown
- 1991-07-18 FI FI913477A patent/FI95254C/fi active
- 1991-07-18 US US07/731,989 patent/US5225414A/en not_active Expired - Fee Related
- 1991-07-18 EP EP19910112045 patent/EP0468372A3/de not_active Withdrawn
- 1991-07-18 PT PT98369A patent/PT98369B/pt not_active IP Right Cessation
- 1991-07-19 CZ CS912259A patent/CZ280584B6/cs unknown
- 1991-07-19 IL IL9889891A patent/IL98898A/en active IP Right Grant
- 1991-07-19 CA CA002047467A patent/CA2047467A1/en not_active Abandoned
- 1991-07-19 NO NO912848A patent/NO179283C/no unknown
- 1991-07-19 NZ NZ239039A patent/NZ239039A/en unknown
- 1991-07-19 RU SU915001058A patent/RU2047604C1/ru active
- 1991-07-19 AU AU81129/91A patent/AU648323B2/en not_active Ceased
- 1991-07-19 JP JP3203665A patent/JPH04234388A/ja active Pending
- 1991-07-19 IE IE255091A patent/IE912550A1/en unknown
- 1991-07-19 HU HU912432A patent/HU212420B/hu not_active IP Right Cessation
- 1991-07-19 ZA ZA915683A patent/ZA915683B/xx unknown
- 1991-07-20 CN CN91104891A patent/CN1031404C/zh not_active Expired - Fee Related
- 1991-07-20 KR KR1019910012470A patent/KR920002598A/ko not_active Application Discontinuation
-
1995
- 1995-05-09 HU HU95P/P00124P patent/HU211918A9/hu unknown
Also Published As
Publication number | Publication date |
---|---|
IL98898A0 (en) | 1992-07-15 |
KR920002598A (ko) | 1992-02-28 |
FI95254C (fi) | 1996-01-10 |
JPH04234388A (ja) | 1992-08-24 |
NO912848D0 (no) | 1991-07-19 |
YU126291A (sh) | 1994-06-24 |
PT98369B (pt) | 1999-01-29 |
AU648323B2 (en) | 1994-04-21 |
US5225414A (en) | 1993-07-06 |
PT98369A (pt) | 1992-05-29 |
NO179283B (no) | 1996-06-03 |
IE912550A1 (en) | 1992-01-29 |
IL98898A (en) | 1995-11-27 |
RU2047604C1 (ru) | 1995-11-10 |
NO179283C (no) | 1996-09-11 |
AU8112991A (en) | 1992-01-23 |
DE4023215A1 (de) | 1992-01-23 |
FI913477A0 (fi) | 1991-07-18 |
ZA915683B (en) | 1992-04-29 |
CS225991A3 (en) | 1992-06-17 |
HU912432D0 (en) | 1991-12-30 |
FI913477A (fi) | 1992-01-22 |
CN1058406A (zh) | 1992-02-05 |
CA2047467A1 (en) | 1992-01-22 |
FI95254B (fi) | 1995-09-29 |
CZ280584B6 (cs) | 1996-02-14 |
NZ239039A (en) | 1994-05-26 |
EP0468372A2 (de) | 1992-01-29 |
HU212420B (en) | 1996-06-28 |
HUT59145A (en) | 1992-04-28 |
EP0468372A3 (en) | 1992-05-06 |
CN1031404C (zh) | 1996-03-27 |
HU211918A9 (en) | 1996-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO912848L (no) | Substituerte azoler, fremgangsmaate for fremstilling deravog anvendelse av forbindelsene. | |
NO900830D0 (no) | Fremgangsmaate for fremstilling av piperidinforbindelser. | |
NO912051D0 (no) | Fremgangsmaate for fremstilling av azolderivater. | |
NO913234D0 (no) | Fremgangsmaate for fremstilling av pyrazolderivater. | |
NO912411D0 (no) | Fremgangsmaate for fremstilling av bicykliske heterocykliske forbindelser. | |
NO890269D0 (no) | Fremgangsmaate for fremstilling av 1,4-disubstituerte-piperidinyl-forbindelser. | |
NO912346L (no) | Fremgangsmaate for fremstilling av aminobenzodiazepiner. | |
NO905008D0 (no) | Fremgangsmaate for fremstilling av heterocykliske forbindelser. | |
NO911122D0 (no) | Fremgangsmaate for fremstilling av antihyperkolesterolemiske midler. | |
NO894583D0 (no) | Fremgangsmaate for fremstilling av celleplast. | |
NO913391D0 (no) | Fremgangsmaate for fremstilling av nye hetrazepinoide syreamider. | |
FI900688A (fi) | Anordning foer luftning av liggunderlag i sjuksaeng. | |
NO911368L (no) | Fremgangsmaate for fremstilling av 2-substituerte alkyl-3-karboksy-karbapenemer. | |
NO913692D0 (no) | Fremgangsmaate for fremstilling av karbapenemforbindelser. | |
NO911118D0 (no) | Fremgangsmaate for fremstilling av nye 8-sulfamylmethylen-2-amino-tetraliner. | |
NO903666L (no) | Fremgangsmaate for fremstilling av pyrrolokinolinforbindelser. | |
NO904535D0 (no) | Fremgangsmaate for fremstilling av fenoxy-heterocykliske forbindelser. | |
NO900381D0 (no) | Fremgangsmaate for fremstilling av nafthalenderivater. | |
NO910894D0 (no) | Fremgangsmaate til fremstilling av cefalosporin. | |
NO911672D0 (no) | Fremgangsmaate for fremstilling av alkansulfonanilid-derivater. | |
NO912673D0 (no) | Fremgangsmaate for fremstilling av 7-amino-4,6-dinitrobenzofuroksan. | |
NO901315D0 (no) | Fremgangsmaate for fremstilling av modifisert pe40. | |
FI903846A (fi) | Anordning foer styrning av ventiluppsaettningen i en arbetsmaskin, saosom en virkeslastare. | |
TR24863A (tr) | ALKALIFOSFAT CÖZELTILERININ üRETILMESINE MAHSUS USUL. | |
NO894285D0 (no) | Framgangsmaate for framstilling av baatskrog. |